On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Professor Rim Abdelmalek, an infectious disease specialist, confirmed that the human papillomavirus (HPV) vaccine is safe and ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

Biopharma giant MSD has received approval for its nine-valent HPV (human papillomavirus) vaccine for use in males aged ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Doses of imported nine-valent human papillomavirus (HPV) vaccine were administered to male recipients in central ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...